Nuclear Med offers a wide variety of studies. The majority of studies require the patient to be injected with a radioactive isotope.
Depending on the study there might be a waiting time before the scan (allowing the isotope enough time to gather in the particular study site). The patient will then be scanned at least once, depending on the study. Please note: a number of the appointment will require patients to return to Nuclear Med repeatedly for up to two days. Please familiarise yourself with the requirements as the radioactive isotopes have sepcific window periods in which they can be scanned
loading...
Octreotide Whole Body - Imported
Preparation for scan is required. Please contact our practice.
Patients are injected with a radioactive tracer (Indium-111 Octreotide). The tracer is taken up by somatostatin receptors in carcinoid tumours (malignant tumours, usually in the digestive tract), multiple myelomas (bone marrow tumours), and endocrine tumours (tumours in the glands). The radioactive Octreotide appears on the scan, allowing the diagnosis of tumours.
Patients will need to be referred to Nuclear Med by a referring doctor. Patients must select the specific scan/study required by their referring doctor and book an appointment at the most convenient location.
Checklist:
Medical aid authorisation (referring doctor to provide patient with specific ICD 10 code for medical aid authorisation)
Referring doctor’s name and practice number
Newly diagnosed oncology patients may need to register for oncology (referring doctor to facilitate registration)
